<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04744909</url>
  </required_header>
  <id_info>
    <org_study_id>SafeTrach 1</org_study_id>
    <nct_id>NCT04744909</nct_id>
  </id_info>
  <brief_title>Navigation System for Percutaneous Tracheotomy</brief_title>
  <official_title>Navigation System for Percutaneous Tracheotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We have studied a new technique for percutaneous tracheotomy. The instrument gives a three&#xD;
      dimensional positioning of the puncture. The technique is used on patients on ENT surgery and&#xD;
      intensiv care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Percutaneous tracheotomy is a well-established method. Anatomical landmarks need to be&#xD;
      identified. We introduce a new method that increases precision through three-dimensional&#xD;
      navigation with a new instrument - SafeTrach.&#xD;
&#xD;
      SafeTrach is a pliers-like instrument. The inner shank acts as a ventilation tube while&#xD;
      stabilizing the orotracheal tube in the trachea. The outer shank acts as a three-dimensional&#xD;
      control instrument for the puncture needle.&#xD;
&#xD;
      We determined the puncture level in 20 patients using SafeTrach. We found that the distance&#xD;
      from the vocal cords to the puncture site was about 45 mm for men and 42 mm for women. This&#xD;
      was based on intraoperative measurements. In 13 patients, we studied the distance between the&#xD;
      vocal cords and the optimal puncture site between the 2nd and 3rd tracheal ring with CT and&#xD;
      found that the mean distance for men was 49.8 mm and for women 42.2 mm. We have used internal&#xD;
      measurements in another 12 patients as follows: The orotracheal tube is positioned so that&#xD;
      the proximal part of the cuff is just below the vocal cords. 2. The position of the tube is&#xD;
      measured against the front teeth. 3. The orotracheal tube together with the inner shank is&#xD;
      pulled up about 15 mm for both men and women. This means that part of the cuff lies between&#xD;
      the vocal cords and you get an acceptable placement of the puncture needle.&#xD;
&#xD;
      By using SafeTrach you can use internal landmarks to indicate the puncture level. The&#xD;
      positioning of the leg is done with high precision because SafeTrach acts as a stable guide.&#xD;
      The navigation system minimizes the risk of extubation and damage to the posterior tracheal&#xD;
      wall.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">August 11, 2020</completion_date>
  <primary_completion_date type="Actual">August 11, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Navigation System for Percutaneous Tracheotomy</measure>
    <time_frame>30 minutes</time_frame>
    <description>Precision of puncture site</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Ventilation Therapy; Complications</condition>
  <condition>Tracheostomy Complication</condition>
  <arm_group>
    <arm_group_label>Percutaneous tracheotomy using a new device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SafeTrach for tracheotomy</intervention_name>
    <description>The navigation system is a forceps-like instrument with an outer and an inner shank. The inner shank serves as a ventilation lumen and stabilizes the orotracheal tube in the midline of trachea. The outer shank acts as a three-dimensional guide for the puncturing needle to the midline of trachea</description>
    <arm_group_label>Percutaneous tracheotomy using a new device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients age &gt;18 years old&#xD;
&#xD;
          -  Patients requiring PDT for prolonged mechanical ventilation, airway protection or&#xD;
             weaning failure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients&#xD;
&#xD;
          -  Emergency tracheotomies&#xD;
&#xD;
          -  Anatomical abnormalities due to hematoma/tumor/scarring from previous neck&#xD;
             surgery/thyromegaly/unstable C-spine and difficult local anatomy. (Patients with&#xD;
             obesity are not considered to be a hindrance for the SafeTrach technique as the&#xD;
             location for puncture easily can be decided with help of the outer and inner shanks).&#xD;
&#xD;
          -  Contra indication for re-intubation (suspected loss of airway during re-intubation)&#xD;
&#xD;
          -  Coagulation abnormalities - INR&gt;1.5, PTT &gt;40, thrombocyte count &lt;50.000&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonas Karling, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <state>Solna</state>
        <zip>171 64</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>February 5, 2021</last_update_submitted>
  <last_update_submitted_qc>February 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Johan Ullman</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Tracheotomy</keyword>
  <keyword>tracheostomy</keyword>
  <keyword>percutaneous dilatational tracheotomy</keyword>
  <keyword>intensive care</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

